Universal Health Services, Inc. filings document the financial results, governance practices and capital structure of a healthcare-services company operating acute care hospitals, behavioral health facilities, outpatient facilities and ambulatory care access points through subsidiaries. Form 8-K reports include operating and financial results, material agreements, credit-facility disclosures and other corporate events.
UHS proxy materials cover shareholder voting matters, board oversight, executive compensation and incentive-plan arrangements. The company’s regulatory disclosures also address risk factors, legal proceedings, ownership and governance matters, and capital actions such as share repurchases, dividends and financing arrangements.
Singer Maria Ruderman reported acquisition or exercise transactions in this Form 4 filing.
Universal Health Services director Maria Ruderman Singer received a grant of 1,217 shares of Class B Common Stock as a stock award, with no cash paid per share. After this grant, she directly holds 9,792 Class B shares.
The award consists of restricted stock units granted under the company’s Amended and Restated 2020 Omnibus Stock and Incentive Plan. All units will vest on the earlier of May 20, 2027 or the next annual stockholder meeting that occurs at least 50 weeks after the May 20, 2026 annual meeting.
Nimetz Warren J. reported acquisition or exercise transactions in this Form 4 filing.
UNIVERSAL HEALTH SERVICES INC director Warren J. Nimetz received an award of 1,217 shares of Class B Common Stock in the form of restricted stock units at no cash cost. The units were granted under the company’s Amended and Restated 2020 Omnibus Stock and Incentive Plan.
All units vest on the earlier of May 20, 2027 or the next annual meeting of stockholders that occurs at least 50 weeks after the May 20, 2026 annual meeting date. Following this award, Nimetz directly holds 9,698 shares of Class B Common Stock.
Universal Health Services, Inc. announced that Matthew J. Peterson, Executive Vice President and President of Behavioral Health, has resigned effective June 19, 2026. He has been with the company since 2019 and plans to pursue a non-competitive external opportunity.
As of the effective date, all of his unvested stock options, restricted stock units and performance-based restricted stock units will terminate. After that date, he will receive only amounts already accrued and vested under company benefit plans and any payments required by law.
Chief Executive Officer and President Marc D. Miller will take on interim leadership of the Behavioral Health Care Division alongside its Senior Vice Presidents, while the company begins an immediate search for a permanent replacement.
Universal Health Services reported higher results for the quarter ended March 31, 2026. Net revenues rose to $4.50 billion from $4.10 billion a year earlier, with growth in both acute care and behavioral health segments, including its U.K. operations.
Net income attributable to UHS increased to $348.7 million, and diluted EPS grew to $5.65 from $4.80. Operating cash flow was strong at $401.6 million, funding $217.2 million of capital spending while total debt stood around $4.7 billion.
The company expanded its credit capacity by $900 million and agreed to acquire Talkspace, Inc. for about $835 million, to be financed under its credit facility. However, it faces significant legal exposure, including the Cumberland Litigation, and its Laurel Ridge Treatment Center has been terminated from Medicare and Medicaid, which is expected to drive operating losses during recertification efforts.
Universal Health Services Inc ownership disclosure: Vanguard Capital Management reports beneficial ownership of 3,922,926 shares of Common Stock, representing 7.28% of the class as reported with an ownership date of 03/31/2026. The filing states Vanguard exercises sole dispositive power over those shares and identifies 470,041 shares as subject to sole voting power. The filing is made on behalf of Vanguard and affiliated advisory units and is signed on 04/30/2026.
Universal Health Services, Inc. reported solid growth for the three months ended March 31, 2026. Net revenues rose 9.6% to $4.495 billion, while net income attributable to UHS increased to $348.7 million, or $5.65 per diluted share, up from $4.80 a year earlier. Adjusted net income was $346.5 million, or $5.62 per diluted share.
EBITDA net of noncontrolling interests was $651.7 million and Adjusted EBITDA net of NCI was $648.3 million. Same-facility acute care net revenues grew 8.2%, driven mainly by higher revenue per admission and patient day, while same-facility behavioral health revenues rose 7.3% on modest volume and pricing gains.
Operating cash flow improved to $401.6 million. The company amended its credit agreement in April 2026 to add an aggregate $900 million of borrowing capacity, including a new $400 million delayed draw term loan A tied to the planned acquisition of Talkspace, Inc., and continued capital returns with 675,000 Class B shares repurchased for about $127.3 million.
Universal Health Services, Inc. amended its long-standing senior secured credit agreement through an Eleventh Amendment, adding new revolving and term loan capacity and updating pricing. The company now has a new $200 million incremental revolving facility, a $300 million incremental tranche A term loan and a $400 million delayed draw term loan under its Senior Secured Credit Facility. The delayed draw term loan is intended to fund the previously announced acquisition of Talkspace, Inc. All incremental loans generally mature on September 26, 2029 and carry margins tied to the company’s Consolidated Net Leverage Ratio. The company also executed supplemental indentures adding new subsidiary guarantors to its various senior secured notes.
Universal Health Services, Inc. is asking stockholders to vote at its 2026 virtual annual meeting on director elections, executive pay, auditor ratification, and two governance-related stockholder proposals. Holders of different share classes elect specific directors and vote together on other items, including a nonbinding say-on-pay resolution and the reappointment of PricewaterhouseCoopers LLP for 2026.
The meeting will be held online on May 20, 2026, for stockholders of record as of March 23, 2026. The Board recommends voting for its director nominees, for executive compensation and auditor ratification, and against the two stockholder proposals on vote reporting and workforce diversity disclosure. The proxy also highlights 2025 results, including consolidated net revenues of $17.36 billion, up 9.7% from 2024, and adjusted diluted EPS of $21.74, a 30.9% increase.
Sim Edward H reported acquisition or exercise transactions in this Form 4 filing.
Universal Health Services Executive Vice President Edward H. Sim received an equity award of 6,404 shares of Class B Common Stock. The filing describes these as restricted stock units granted under the company’s Amended and Restated 2020 Omnibus Stock and Incentive Plan, vesting in equal portions on March 26 of 2027, 2028, 2029 and 2030. Following this grant, Sim directly holds 24,790 shares, reflecting routine, compensation-related equity rather than an open-market purchase.